The Jewish Hospital - Mercy Health Seeks Patients with Blood Cancers for Clinical Research Studies
(CINCINNATI; July 2, 2012) – The clinical trials team at the Blood and Marrow Transplant Center at The Jewish Hospital – Mercy Health is seeking qualified patients for a number of national and international clinical research studies focused on blood cancers. Currently, the team has openings for patients with the following conditions:
Leukemia:
• Acute Lymphoblastic Leukemia (ALL): A cooperative research study for adolescents and young adults up to 40 years old with untreated Acute Lymphoblastic Leukemia (ALL) Philadelphia negative.
• Acute Myeloid Leukemia (AML): A cooperative research study for newly diagnosed adults over 60 years old with AML.
• Acute Myeloid Leukemia (AML): A cooperative research study for adults 70 years old or younger whose AML has returned or whose current treatment for AML is not working.
• Acute Myeloid Leukemia (AML): A pharmaceutical research study for adults with AML that have been heavily treated for their disease.
• Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS): A cooperative research study comparing two kinds of treatment used to destroy diseased cells and prepare your body for transplant.
Multiple Myeloma:
• A cooperative research study designed to determine which treatment strategy will best keep multiple myeloma in remission for the longest time.
Amyloidosis (A disease in which a type of protein collects in multiple areas of the body):
• A cooperative research study to compare a standard two-drug combination therapy with a proposed new combination of standard plus an additional drug in treating patients with previously untreated systemic amyloidosis.
Chronic graft versus host disease (when donor cells attack and damage your tissues after an allogeneic stem cell transplant):
• A cooperative research study to compare two treatments for chronic graft versus host disease.
The team also seeks the following:
• Patients who’ve had an autologous stem cell transplant for a shingles vaccine study that will examine the safety of the medicine and patients’ ability to tolerate the vaccine
• Patients donating stem cells to a relative for a national study on donor quality of life.
To learn more about these studies or find out if you qualify, please contact the Blood and Marrow Transplant Center at (513) 686-5482.
The Jewish Hospital – Mercy Health is one of Cincinnati’s premier cancer care centers, offering a full spectrum of cancer treatments including the only FACT (Foundation for the Accreditation of Cellular Therapy) accredited Blood & Marrow Transplant Center, the first adult bone marrow transplant program in the region and the only one offering allogeneic (unrelated donors), autologous (self-donor), haploidentical (sibling who is a half-match), and umbilical cord transplants.
|
